{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:17:33Z","timestamp":1775153853571,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,3]]},"DOI":"10.7759\/cureus.9535","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T17:47:05Z","timestamp":1596476825000},"source":"Crossref","is-referenced-by-count":15,"title":["Convalescent Plasma Therapy and Its Effects On COVID-19 Patient Outcomes: A Systematic Review of Current Literature"],"prefix":"10.7759","author":[{"given":"Nabiyah","family":"Bakhtawar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Usman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malik Muhammad Uzair","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. coronavirus disease 2019 (COVID\u201019) \u2010 Situation Report 175. (2020). Accessed: July 13, 2020: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200713-covid-19-sitrep-175.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30195-X","article-title":"Real estimates of mortality following COVID-19 infection","volume":"12","author":"Baud D","year":"2020","unstructured":"Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020, 12:773. 10.1016\/S1473-3099(20)30195-X","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2020.04.001","article-title":"Evidence based management guideline for the COVID-19 pandemic - review article","volume":"77","author":"Nicola M","year":"2020","unstructured":"Nicola M, O'Neill N, Sohrabi C, Khan M, Agha M, Agha R. Evidence based management guideline for the COVID-19 pandemic - review article. Int J Surg. 2020, 77:206-216. 10.1016\/j.ijsu.2020.04.001","journal-title":"Int J Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2450\/2015.0131-15","article-title":"Convalescent plasma: new evidence for an old therapeutic tool?","volume":"14","author":"Marano G","year":"2016","unstructured":"Marano G, Vaglio S, Pupella S, et al.. Convalescent plasma: new evidence for an old therapeutic tool?. Blood Transfus. 2016, 14:152-157. 10.2450\/2015.0131-15","journal-title":"Blood Transfus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1511812","article-title":"Evaluation of convalescent plasma for Ebola virus disease in Guinea","volume":"374","author":"Griensven J","year":"2016","unstructured":"Griensven J, Edwards T, de Lamballerie X, et al.. Evaluation of convalescent plasma for Ebola virus disease in Guinea. N Engl J Med. 2016, 374:33-42. 10.1056\/NEJMoa1511812","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"15","author":"Hung I","year":"2011","unstructured":"Hung I, To K, Lee C, et al.. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis. 2011, 15:447-456. 10.1093\/cid\/ciq106","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8","article-title":"State of knowledge and data gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in humans","volume":"12","author":"The WHO MERS-CoV Research Group","year":"2013","unstructured":"The WHO MERS-CoV Research Group. State of knowledge and data gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in humans. PLoS Curr. 2013, 12:5. 10.1371\/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8","journal-title":"PLoS Curr"},{"key":"ref8","article-title":"Treatment of severe acute respiratory syndrome with convalescent plasma","volume":"9","author":"Wong V","year":"2003","unstructured":"Wong V, Dai D, Wu A, Sung J. Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J. 2003, 9:199-201.","journal-title":"Hong Kong Med J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013600","article-title":"Convalescent plasma or hyperimmune immunoglobulin for people with COVID- 19: a rapid review","volume":"5","author":"Valk S","year":"2020","unstructured":"Valk S, Piechotta V, Chai K, et al.. Convalescent plasma or hyperimmune immunoglobulin for people with COVID- 19: a rapid review. Cochrane Database Syst Rev. 2020, 5:013600. 10.1002\/14651858.CD013600","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e149","article-title":"Use ofconvalescent plasma therapy in two COVID-19 patients withacute respiratory distress syndrome in Korea","volume":"35","author":"Ahn J","year":"2020","unstructured":"Ahn J, Sohn Y, Lee S, et al.. Use ofconvalescent plasma therapy in two COVID-19 patients withacute respiratory distress syndrome in Korea. J Korean Med Sci. 2020, 35:e149. 10.3346\/jkms.2020.35.e149","journal-title":"J Korean Med Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"28","author":"Duan K","year":"2020","unstructured":"Duan K, Liu B, Li C, et al.. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci USA . 2020, 28:9490-9496. 10.1073\/pnas.2004168117","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.07.20056440","article-title":"Convalescent plasma to treat COVID- 19: Chinese strategy andexperiences (PREPRINT)","author":"Pei S","year":"2020","unstructured":"Pei S, Yuan X, Zhimin Z, et al.. Convalescent plasma to treat COVID- 19: Chinese strategy andexperiences (PREPRINT). medRxiv. 2020, 10.1101\/2020.04.07.20056440","journal-title":"medRxiv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen C","year":"2020","unstructured":"Shen C, Wang Z, Zhao F, et al.. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020, 323:1582-1589. 10.1001\/jama.2020.4783","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.22.20040071","article-title":"A special case of COVID-19 with long duration of viral shedding for 49 days (PREPRINT)","author":"Tan L","year":"2020","unstructured":"Tan L, Kang X, Zhang B, et al.. A special case of COVID-19 with long duration of viral shedding for 49 days (PREPRINT). medRxiv. 2020, 10.1101\/2020.03.22.20040071","journal-title":"medRxiv"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25882","article-title":"Treatment with convalescent plasma for COVID-19 patients in Wuhan, China (IN PRESS)","author":"Ye M","year":"2020","unstructured":"Ye M, Fu D, Ren Y, et al.. Treatment with convalescent plasma for COVID-19 patients in Wuhan, China (IN PRESS). J Med Virol. 2020, 10.1002\/jmv.25882","journal-title":"J Med Virol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.03.039","article-title":"Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection","volume":"31","author":"Zhang B","year":"2020","unstructured":"Zhang B, Liu S, Tan T, et al.. Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection. Chest. 2020, 31:E9-E13. 10.1016\/j.chest.2020.03.039","journal-title":"Chest"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103102","article-title":"Anti-SARS-CoV-2virus antibody levels in convalescent plasma of six donors whohave recovered from COVID-19","volume":"12","author":"Zhang L","year":"2020","unstructured":"Zhang L, Pang R, Xue X, et al.. Anti-SARS-CoV-2virus antibody levels in convalescent plasma of six donors whohave recovered from COVID-19. Aging. 2020, 12:6536-6542. 10.18632\/aging.103102","journal-title":"Aging"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa228","article-title":"Effect of convalescent plasma therapy on viral shedding and survival in patients with coronavirus disease","volume":"222","author":"Zeng Q","year":"2020","unstructured":"Zeng Q, Yu Z, Gou J, et al.. Effect of convalescent plasma therapy on viral shedding and survival in patients with coronavirus disease. J Infect Dis. 2020, 222:38-43. 10.1093\/infdis\/jiaa228","journal-title":"J Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19","author":"Li L","year":"2020","unstructured":"Li L, Zhang W, Hu Y, et al.. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19. JAMA. 2020, 10.1001\/jama.2020.10044","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf0972","article-title":"HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1","volume":"352","author":"Schoofs T","year":"2016","unstructured":"Schoofs T, Klein F, Braunschweig M. HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1. Science. 2016, 352:997-1001. 10.1126\/science.aaf0972","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1279","article-title":"Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo","volume":"352","author":"Lu C","year":"2016","unstructured":"Lu C, Murakowski D, Bournazos S. Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo. Science. 2016, 352:1001-1004. 10.1126\/science.aaf1279","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng Y","year":"2005","unstructured":"Cheng Y, Wong R, Soo Y, et al.. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005, 24:44-46. 10.1007\/s10096-004-1271-9","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"52","author":"Hung I","year":"2011","unstructured":"Hung I, To K, Lee C. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis. 2011, 52:447-456. 10.1093\/cid\/ciq106","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104358","article-title":"Challenges of Convalescent Plasma Therapy on COVID-19","volume":"127","author":"Zhao Q","year":"2020","unstructured":"Zhao Q, He Y. Challenges of Convalescent Plasma Therapy on COVID-19. J Clin Virol. 2020, 127:104358. 10.1016\/j.jcv.2020.104358","journal-title":"J Clin Virol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2005.01.033","article-title":"Risks and side effects of therapy with plasma and plasma fractions","volume":"19","author":"MacLennan S","year":"2006","unstructured":"MacLennan S, Barbara J. Risks and side effects of therapy with plasma and plasma fractions. Best Pract Res Clin Haematol. 2006, 19:169-189. 10.1016\/j.beha.2005.01.033","journal-title":"Best Pract Res Clin Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/37482-convalescent-plasma-therapy-and-its-effects-on-covid-19-patient-outcomes-a-systematic-review-of-current-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:23:52Z","timestamp":1707506632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/37482-convalescent-plasma-therapy-and-its-effects-on-covid-19-patient-outcomes-a-systematic-review-of-current-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.9535","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,3]]}}}